The fundamental idea is to use computer modeling to discover a structure that will mimic the glycoprotien(s) on the surface of cells to which the virus will attach.
The next challenge is to find out how to make that molecule in quantity, repeatedly, and to required standards.
Another problem might be in the manufacture of a micelle of an effective kind, and the attachment of the ligand to those micelles, etc.
Then there could be two more fatal problems: 1) the viruses will not at all or sufficiently attach to the ligands, 2) if attached, the micelle will not merge itself with the envelope of the virus and destroy it.
Is there something wrong with any of these, other than that each is hard to do and would take a long time to get right, if ever?
If none of the above is the problem, as you see it, then what is?
Or perhaps you think that even if all the above is possible that Diwan is incapable of doing it, although someone else might succeed?
I'm genuinely interested in your answer.
Market Data 
Markets 
AI
